The mechanism of budding of retroviruses from cell membranes

Advances in Virology

Volumn 2009, Issue , 2009, Pages

  Pincetic, Andrew ^a   Leis, Jonathan ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AVES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 70949097575     PISSN: 16878639     EISSN: 16878647     Source Type: Journal    
DOI: 10.1155/2009/623969     Document Type: Review

References (69)

1. Klein K. C., Reed J. C., Lingappa J. R., jais@u.washington.edu Intracellular destinies: degradation, targeting, assembly, and endocytosis of HIV Gag. AIDS Reviews 2007 9 3 150 161 (Pubitemid 350001486)
2. Tritel M., Resh M. D., m-resh@ski.mskcc.org The late stage of human immunodeficiency virus type 1 assembly is an energy-dependent process. Journal of Virology 2001 75 12 5473 5481 10.1128/JVI.75.12.5473-5481.2001 (Pubitemid 32488140)
3. Göttlinger H. G., Dorfman T., Sodroski J. G., Haseltine W. A., Effect of mutations affecting the p6 Gag protein on human immunodeficiency virus particle release. Proceedings of the National Academy of Sciences of the United States of America 1991 88 8 3195 3199 10.1073/pnas.88.8.3195 (Pubitemid 21916586)
4. Wills J. W., Cameron C. E., Wilson C. B., Xiang Y., Bennett R. P., Leis J., An assembly domain of the Rous sarcoma virus Gag protein required late in budding. Journal of Virology 1994 68 10 6605 6618 (Pubitemid 24294911)
5. Xiang Y., Cameron C. E., Wills J. W., Leis J., Fine mapping and characterization of the Rous sarcoma virus Pr 76gag late assembly domain. Journal of Virology 1996 70 8 5695 5700 (Pubitemid 26240754)
6. Huang M., Orenstein J. M., Martin M. A., Freed E. O., p 6 Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. Journal of Virology 1995 69 11 6810 6818
7. Freed E. O., Viral late domains. Journal of Virology 2002 76 10 4679 4687 10.1128/JVI.76.10.4679-4687.2002 (Pubitemid 34441674)
8. Schmitt A. P., Leser G. P., Morita E., Sundquist W. I., Lamb R. A., ralamb@northwestern.edu Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. Journal of Virology 2005 79 5 2988 2997 10.1128/JVI.79.5.2988-2997.2005 (Pubitemid 40270578)
9. Li F., Chen C., Puffer B. A., Montelaro R. C., Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication. Journal of Virology 2002 76 4 1569 1577 10.1128/JVI.76.4.1569-1577.2002 (Pubitemid 34094603)
10. Ott D. E., ott@ncifcrf.gov Coren L. V., Gagliardi T. D., Nagashima K., Heterologous late-domain sequences have various abilities to promote budding of human immunodeficiency virus type 1. Journal of Virology 2005 79 14 9038 9045 10.1128/JVI.79.14.9038-9045.2005 (Pubitemid 40934814)
11. Martin-Serrano J., Perez-Caballero D., Bieniasz P. D., pbienias@adarc.org Context-dependent effects of L domains and ubiquitination on viral budding. Journal of Virology 2004 78 11 5554 5563 10.1128/JVI.78.11.5554-5563.2004 (Pubitemid 38661642)
12. Chung H.-Y., Morita E., von Schwedler U., Müller B., Kräusslich H.-G., Sundquist W. I., wes@biochem.utah.edu NEDD4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains. Journal of Virology 2008 82 10 4884 4897 10.1128/JVI.02667-07 (Pubitemid 351657050)
13. Gottwein E., Bodem J., Müller B., Schmechel A., Zentgraf H., Kräusslich H.-G., Hans-Georg-Kraeusslich@med.uni-heidelberg.de The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release. Journal of Virology 2003 77 17 9474 9485 10.1128/JVI.77.17.9474-9485.2003 (Pubitemid 37011043)
14. Blot V., Perugi F., Gay B., Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding. Journal of Cell Science 2004 117 11 2357 2367 10.1242/jcs.01095 (Pubitemid 38807502)
15. Strack B., Calistri A., Craig S., Popova E., Göttlinger H. G., heinrich-gottlinger@dfci.harvard.edu AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 2003 114 6 689 699 10.1016/S0092-8674(03)00653-6 (Pubitemid 37186765)
16. VerPlank L., Agresta B., Grassa T., Kikonyogo A., Leis J., Carter C., Tsg101, the prototype of a class of dominant-negative ubiquitin regulators, binds human immunodeficiency virus type 1 Pr 55Gag: the L domain is a determining of binding. Poceedings of the National Academy of Sciences of the United States of America 2001 98 7724 7729
17. von Schwedler U. K., Stuchell M., Müller B., The protein network of HIV budding. Cell 2003 114 6 701 713 10.1016/S0092-8674(03)00714-1 (Pubitemid 37203363)
18. Lee S., Joshi A., Nagashima K., Freed E. O., Hurley J. H., hurley@helix.nih.gov Structural basis for viral late-domain binding to Alix. Nature Structural and Molecular Biology 2007 14 3 194 199 10.1038/nsmb1203 (Pubitemid 46355573)
19. Vincent O., ovincent@cib.csic.es Rainbow L., Tilburn J., Arst H. N. Jr., Peñalva M. A., YPXL/I is a protein interaction motif recognized by Aspergillus PalA and its human homologue, AIP1/Alix. Molecular and Cellular Biology 2003 23 5 1647 1655 10.1128/MCB.23.5.1647-1655.2003 (Pubitemid 36246046)
20. Fisher R. D., Chung H.-Y., Zhai Q., Robinson H., Sundquist W. I., wes@biochem.utah.edu Hill C. P., chris@biochem.utah.edu Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell 2007 128 5 841 852 10.1016/j.cell.2007.01.035 (Pubitemid 46341413)
21. Kikonyogo A., Bouamr F., Vana M. L., Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for Gag budding from cells. Proceedings of the National Academy of Sciences of the United States of America 2001 98 20 11199 11204 10.1073/pnas.201268998 (Pubitemid 32928706)
22. Martin-Serrano J., Eastman S. W., Chung W., Bieniasz P. D., pbienias@adarc.org HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. Journal of Cell Biology 2005 168 1 89 101 10.1083/jcb.200408155 (Pubitemid 40111060)
23. Hurley J. H., hurley@helix.nih.gov Emr S. D., semr@ucsd.edu The ESCRT complexes: structure and mechanism of a membrane-trafficking network. Annual Review of Biophysics and Biomolecular Structure 2006 35 277 298 10.1146/annurev.biophys.35.040405.102126 (Pubitemid 43877379)
24. Stuchell-Brereton M. D., Skalicky J. J., Kieffer C., Karren M. A., Ghaffarian S., Sundquist W. I., ESCRT-III recognition by VPS4 ATPases. Nature 2007 449 7163 740 744 10.1038/nature06172 (Pubitemid 47552091)
25. Muzioł T., Pineda-Molina E., Ravelli R. B., Structural basis for budding by the ESCRT-III factor CHMP3. Developmental Cell 2006 10 6 821 830 10.1016/j.devcel.2006.03.013 (Pubitemid 43779119)
26. Medina G., Zhang Y., Tang Y., The functionally exchangeable L domains in RSV and HIV-1 Gag direct particle release through pathways linked by Tsg101. Traffic 2005 6 10 880 894 10.1111/j.1600-0854.2005.00323.x (Pubitemid 41309397)
27. Garrus J. E., von Schwedler U. K., Pornillos O. W., Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 2001 107 1 55 65 10.1016/S0092-8674(01)00506-2 (Pubitemid 32972037)
28. Shehu-Xhilaga M., Ablan S., Demirov D. G., Chen C., Montelaro R. C., Freed E. O., efreed@mail.nih.gov Late domain-dependent inhibition of equine infectious anemia virus budding. Journal of Virology 2004 78 2 724 732 10.1128/JVI.78.2.724-732.2004 (Pubitemid 38067594)
29. Vana M. L., Tang Y., Chen A., Medina G., Carter C., Leis J., j-leis@northwestern.edu Role of Nedd4 and ubiquitination of Rous sarcoma virus Gag in budding of virus-like particles from cells. Journal of Virology 2004 78 24 13943 13953 10.1128/JVI.78.24.13943-13953.2004 (Pubitemid 39612791)
30. Usami Y., Popov S., Popova E., Göttlinger H. G., heinrich.gottlinger@umassmed.edu Efficient and specific rescue of human immunodeficiency virus type 1 budding defects by a Nedd4-like ubiquitin ligase. Journal of Virology 2008 82 10 4898 4907 10.1128/JVI.02675-07 (Pubitemid 351657051)
31. Medina G., Pincetic A., Ehrlich L. S., Tsg101 can replace Nedd4 function in ASV Gag release but not membrane targeting. Virology 2008 377 1 30 38 10.1016/j.virol.2008.04.024 (Pubitemid 351799835)
32. Martin-Serrano J., Zang T., Bieniasz P. D., pbienias@adarc.org Role of ESCRT-I in retroviral budding. Journal of Virology 2003 77 8 4794 4804 10.1128/JVI.77.8.4794-4804.2003 (Pubitemid 36402829)
33. Stuchell M. D., Garrus J. E., Müller B., The human endosomal sorting complex required for transport (ESCRT-I) and its role in HIV-1 budding. The Journal of Biological Chemistry 2004 279 34 36059 36071 10.1074/jbc.M405226200 (Pubitemid 39100614)
34. Pincetic A., Medina G., Carter C., Leis J., j-leis@northwestern.edu Avian sarcoma virus and human immunodeficiency virus, type 1 use different subsets of ESCRT proteins to facilitate the budding process. The Journal of Biological Chemistry 2008 283 44 29822 29830 10.1074/jbc.M804157200
35. Langelier C., von Schwedler U. K., Fisher R. D., Human ESCRT-II complex and its role in human immunodeficiency virus type 1 release. Journal of Virology 2006 80 19 9465 9480 10.1128/JVI.01049-06 (Pubitemid 44435625)
36. Shim S., Kimpler L. A., Hanson P. I., phanson22@wustl.edu Structure/function analysis of four core ESCRT-III proteins reveals common regulatory role for extreme C-terminal domain. Traffic 2007 8 8 1068 1079 10.1111/j.1600-0854.2007.00584.x (Pubitemid 47074039)
37. Zamborlini A., Usami Y., Radoshitzky S. R., Popova E., Palu G., Göttlinger H., heinrich.gottlinger@umassmed.edu Release of autoinhibition converts ESCRT-III components into potent inhibitors of HIV-1 budding. Proceedings of the National Academy of Sciences of the United States of America 2006 103 50 19140 19145 10.1073/pnas.0603788103 (Pubitemid 350002840)
38. Hanson P. I., phanson22@wustl.edu Roth R., Lin Y., Heuser J. E., Plasma membrane deformation by circular arrays of ESCRT-III protein filaments. Journal of Cell Biology 2008 180 2 389 402 10.1083/jcb.200707031 (Pubitemid 351185923)
39. Lata S., Schoehn G., Jain A., Helical structures of ESCRT-III are disassembled by VPS4. Science 2008 321 5894 1354 1357 10.1126/science.1161070
40. Ghazi-Tabatabai S., Saksena S., Short J. M., Structure and disassembly of filaments formed by the ESCRT-III subunit Vps24. Structure 2008 16 9 1345 1356 10.1016/j.str.2008.06.010
41. Agromayor M., Martin-Serrano J., juan.martin-serrano@kcl.ac.uk Interaction of AMSH with ESCRT-III and deubiquitination of endosomal cargo. The Journal of Biological Chemistry 2006 281 32 23083 23091 10.1074/jbc.M513803200
42. Umebayashi K., kumebaya@lab.nig.ac.jp The roles of ubiquitin and lipids in protein sorting along the endocytic pathway. Cell Structure and Function 2003 28 5 443 453 10.1247/csf.28.443 (Pubitemid 38256612)
43. Futter C. E., Collinson L. M., Backer J. M., Hopkins C. R., colinhopkins@compuserve.ac.uk Human VPS34 is required for internal vesicle formation within multivesicular endosomes. Journal of Cell Biology 2001 155 7 1251 1263 10.1083/jcb.200108152 (Pubitemid 34286274)
44. Putterman D., Pepinsky R. B., Vogt V. M., Ubiquitin in avian leukosis virus particles. Virology 1990 176 2 633 637 10.1016/0042-6822(90)90035-P (Pubitemid 20177055)
45. Ott D. E., ott@avpvx1.ncifcrf.gov Coren L. V., Copeland T. D., Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus. Journal of Virology 1998 72 4 2962 2968 (Pubitemid 28175534)
46. Ott D. E., ott@ncifcrf.gov Coren L. V., Sowder R. C. II, Adams J., Schubert U., Retroviruses have differing requirements for proteasome function in the budding process. Journal of Virology 2003 77 6 3384 3393 10.1128/JVI.77.6.3384-3393.2003 (Pubitemid 36297257)
47. Schubert U., uschubert@nih.gov Ott D. E., Chertova E. N., Proteasome inhibition interferes with Gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proceedings of the National Academy of Sciences of the United States of America 2000 97 24 13057 13062 10.1073/pnas.97.24.13057
48. Patnaik A., Chau V., Wills J. W., jwills@psu.edu Ubiquitin is part of the retrovirus budding machinery. Proceedings of the National Academy of Sciences of the United States of America 2000 97 24 13069 13074 10.1073/pnas.97.24.13069
49. Gottwein E., Jäger S., Habermann A., Kräusslich H.-G., Hans-Georg.Kraeusslich@med.uni-heidelberg.de Cumulative mutations of ubiquitin acceptor sites in human immunodeficiency virus type 1 Gag cause a late budding defect. Journal of Virology 2006 80 13 6267 6275 10.1128/JVI.02177-05 (Pubitemid 43927429)
50. Spidel J. L., Craven R. C., Wilson C. B., Lysines close to the Rous sarcoma virus late domain critical for budding. Journal of Virology 2004 78 19 10606 10616 10.1128/JVI.78.19.10606-10616.2004 (Pubitemid 39258387)
51. Heidecker G., heidecke@ncifcrf.gov Lloyd P. A., Soheilian F., Nagashima K., Derse D., The role of WWP1-Gag interaction and Gag ubiquitination in assembly and release of human T-cell leukemia virus type 1. Journal of Virology 2007 81 18 9769 9777 10.1128/JVI.00642-07 (Pubitemid 350067681)
52. Strack B., Calistri A., Göttlinger H. G., Late assembly domain function can exhibit context dependence and involves ubiquitin residues implicated in endocytosis. Journal of Virology 2002 76 11 5472 5479 10.1128/JVI.76.11.5472-5479.2002 (Pubitemid 34517897)
53. Pornillos O., Alam S. L., Rich R. L., Myszka D. G., Davis D. R., Sundquist W. I., Structure and functional interactions of the Tsg101 UEV domain. The EMBO Journal 2002 21 10 2397 2406 10.1093/emboj/21.10.2397 (Pubitemid 34546712)
54. Goff A., Ehrlich L. S., Cohen S. N., Carter C. A., ccarter@ms.cc.sunysb. edu Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release. Journal of Virology 2003 77 17 9173 9182 10.1128/JVI.77.17.9173-9182. 2003 (Pubitemid 37011014)
55. Joshi A., Munshi U., Ablan S. D., Nagashima K., Freed E. O., efreed@nih.gov Functional replacement of a retroviral late domain by ubiquitin fusion. Traffic 2008 9 11 1972 1983 10.1111/j.1600-0854.2008.00817.x
56. Zhadina M., McClure M. O., Johnson M. C., Bieniasz P. D., pbienias@adarc.org Ubiquitin-dependent virus particle budding without viral protein ubiquitination. Proceedings of the National Academy of Sciences of the United States of America 2007 104 50 20031 20036 10.1073/pnas.0708002104
57. Randazzo P. A., Terui T., Sturch S., Fales H. M., Ferrige A. G., Kahn R. A., The myristoylated amino terminus of ADP-ribosylation factor 1 is a phospholipid- and GTP-sensitive switch. The Journal of Biological Chemistry 1995 270 24 14809 14815 10.1074/jbc.270.24.14809
58. Gangal M., Clifford T., Deich J., Cheng X., Taylor S. S., Johnson D. A., david.johnson@ucr.edu Mobilization of the A-kinase N -myristate through an isoform-specific intermolecular switch. Proceedings of the National Academy of Sciences of the United States of America 1999 96 22 12394 12399 10.1073/pnas.96.22.12394 (Pubitemid 29513513)
59. Spearman P., paul.spearman@mcmail.vanderbilt.edu Horton R., Ratner L., Kuli-Zade I., Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. Journal of Virology 1997 71 9 6582 6592 (Pubitemid 27355316)
60. Perez-Caballero D., Hatziioannou T., Martin-Serrano J., Bieniasz P. D., pbienias@adarc.org Human immunodeficiency virus type 1 matrix inhibits and confers cooperativity on Gag precursor-membrane interactions. Journal of Virology 2004 78 17 9560 9563 10.1128/JVI.78.17.9560-9563.2004 (Pubitemid 39096563)
61. Ono A., Demirov D., Freed E. O., EFreed@nih.gov Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding. Journal of Virology 2000 74 11 5142 5150 10.1128/JVI.74.11.5142-5150.2000 (Pubitemid 30313854)
62. Ono A., Orenstein J. M., Freed E. O., EFreed@nih.gov Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly. Journal of Virology 2000 74 6 2855 2866 10.1128/JVI.74.6.2855-2866.2000 (Pubitemid 30117597)
63. Ono A., aono@ncifcrf.gov Ablan S. D., Lockett S. J., Nagashima K., Freed E. O., Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proceedings of the National Academy of Sciences of the United States of America 2004 101 41 14889 14894 10.1073/pnas.0405596101 (Pubitemid 39410770)
64. Chukkapalli V., Hogue I. B., Boyko V., Hu W.-S., Ono A., Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient Gag membrane binding. Journal of Virology 2008 82 5 2405 2417 10.1128/JVI.01614-07 (Pubitemid 351293541)
65. Chen K., Bachtiar I., Piszczek G., Bouamr F., Carter C., ccarter@ms.cc.sunysb.edu Tjandra N., tjandran@nhlbi.nih.gov Solution NMR characterizations of oligomerization and dynamics of equine infectious anemia virus matrix protein and its interaction with PIP2. Biochemistry 2008 47 7 1928 1937 10.1021/bi701984h (Pubitemid 351287118)
66. Saad J. S., Miller J., Tai J., Kim A., Ghanam R. H., Summers M. F., summers@hhmi.umbc.edu Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proceedings of the National Academy of Sciences of the United States of America 2006 103 30 11364 11369 10.1073/pnas.0602818103 (Pubitemid 44156523)
67. Figueiredo A., Hope T. J., Leis J.,. unpublished observation
68. Vidal M., mvidal@univ-montp2.fr Mangeat P., Hoekstra D., Aggregation reroutes molecules from a recycling to a vesicle-mediated secretion pathway during reticulocyte maturation. Journal of Cell Science 1997 110 16 1867 1877 (Pubitemid 27384788)
69. Willem J., ter Beest M., Scherphof G., Hoekstra D., A non-exchangeable fluorescent phospholipid anolog as a membrane traffic marker of the endocytic pathway. European Journal of Cell Biology 1990 53 1 173 184 (Pubitemid 20368197)